Need help finding what you are looking for?
Contact Us
PUBLISHER: The Business Research Company | PRODUCT CODE: 1034445
PUBLISHER: The Business Research Company | PRODUCT CODE: 1034445
AI In Pharma Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
PUBLISHED:
PAGES: 256 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
“AI In Pharma Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global AI in pharma market as it emerges from the COVID 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Where is the largest and fastest growing market for AI in pharma? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The AI in pharma market global report” from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider AI in pharma market; and compares it with other markets.
The report covers the following chapters:
- Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
- Report Structure - This section gives the structure of the report and the information covered in the various sections.
- Introduction - The introduction section of the report gives brief introduction about segmentation by technology, segmentation by drug type and segmentation by application.
- Market Characteristics - The market characteristics section of the report defines and explains artificial intelligence (AI) in pharma market. This chapter also defines and describes goods and related services covered in the report.
- Trends And Strategies - This chapter describes the major trends shaping the global artificial intelligence (AI) in pharma market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Impact of COVID-19 - This section describes the impact of COVID-19 on the artificial intelligence (AI) in pharma market.
- Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
- Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
- Global Macro Comparison - The global artificial intelligence (AI) in pharma market comparison with macro-economic factors gives the artificial intelligence (AI) in pharma market size, percentage of GDP, and average artificial intelligence (AI) in pharma market expenditure.
- Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
- Competitive Landscape - This section covers details on the competitive landscape of the global artificial intelligence (AI) in pharma market, estimated market shares and company profiles for the leading players.
- Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for AI in pharma companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
- 1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
- 2) By Drug Type: Small Molecule; Large Molecule
- 3) By Application: Clinical Trial Research; Drug Discovery; Research And Development; Others
- Companies Mentioned: IBM Watson Health; Alphabet Inc.; Concreto HealthAI; Nvidia Corporation; PathAI
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; AI in pharma indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: o&s325
Table of Contents
1. AI In Pharma Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
- 6.1. Segmentation By Geography
- 6.2. Segmentation By Technology
- 6.3. Segmentation By Drug Type
- 6.4. Segmentation By Application
7. AI In Pharma Market Characteristics
- 7.1. Market Definition
- 7.2. Segmentation By Technology
- 7.2.1. Context-Aware Processing
- 7.2.2. Natural Language Processing
- 7.2.3. Querying Method
- 7.2.4. Deep Learning
- 7.3. Market Segmentation By Drug Type
- 7.3.1. Small Molecules
- 7.3.2. Large Molecules
- 7.4. Segmentation By Application
- 7.4.1. Clinical Trial Research
- 7.4.2. Drug Discovery
- 7.4.3. Research And Development
- 7.4.4. Others
8. AI In Pharma Market Trends And Strategies
- 8.1. Use Of AI For Clinical Trials
- 8.2. AI For Rare Diseases Treatment
- 8.3. AI For Drug Adherence
- 8.4. Investments in AI Driven Biotech Firms
- 8.5. Rise In Merger And Acquisition Activity
- 8.6. Introduction of New Artificial Intelligence (AI) Tools
- 8.7. Emerging Role of CROs in AI Ecosystems
- 8.8. Introduction of AI Innovation Labs
9. Impact Of COVID-19 On The AI In Pharma Market
- 9.1. Introduction
- 9.2. Use Of AI For Vaccine Development
- 9.3. Clinical Trials
- 9.4. Future Outlook
10. Global AI In Pharma Market Size And Growth
- 10.1. Market Size
- 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
- 10.2.1. Drivers Of The Market 2015 - 2020
- 10.2.2. Restraints On The Market 2015 - 2020
- 10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 10.3.1. Drivers Of The Market 2020 - 2025
- 10.3.2. Restraints On The Market 2020 - 2025
11. Global AI In Pharma Market Segmentation
- 11.1. Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 11.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 11.3. Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12. AI In Pharma Market, Regional And Country Analysis
- 12.1. Global AI In Pharma Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 12.2. Global AI In Pharma Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific AI In Pharma Market
- 13.1. Asia-Pacific AI In Pharma Market Overview
- 13.1.1. Region Information
- 13.1.2. Market Information
- 13.1.3. COVID-19 Impact
- 13.1.4. Background Information
- 13.1.5. Government Initiatives
- 13.1.6. Regulations
- 13.1.7. Regulatory Bodies
- 13.1.8. Major Associations
- 13.1.9. Taxes levied
- 13.1.10. Corporate Tax Structure
- 13.1.11. Investments
- 13.1.12. Major Companies
- 13.2. Asia-Pacific AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.3. Asia-Pacific AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.4. Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.5. Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.6. Asia-Pacific AI In Pharma Market: Country Analysis
- 13.7. China AI In Pharma Market
- 13.8. China AI In Pharma Market Overview
- 13.8.1. Country Information
- 13.8.2. Market Information
- 13.8.3. COVID-19 Impact
- 13.8.4. Background Information
- 13.8.5. Government Initiatives
- 13.8.6. Regulations
- 13.8.7. Regulatory Bodies
- 13.8.8. Major Associations
- 13.8.9. Taxes Levied
- 13.8.10. Corporate Tax Structure
- 13.8.11. Investments
- 13.8.12. Major Companies
- 13.9. China AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.10. China AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.11. China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.12. China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.13. India AI In Pharma Market
- 13.14. India AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.15. India AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.16. India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.17. India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.18. Japan AI In Pharma Market
- 13.19. Japan AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.20. Japan AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.21. Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.22. Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.23. Australia AI In Pharma Market
- 13.24. Australia AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.25. Australia AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.26. Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.27. Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.28. Indonesia AI In Pharma Market
- 13.29. Indonesia AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.30. Indonesia AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.31. Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.32. Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.33. South Korea AI In Pharma Market
- 13.34. South Korea AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 13.35. South Korea AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 13.36. South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 13.37. South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe AI In Pharma Market
- 14.1. Western Europe AI In Pharma Market Overview
- 14.1.1. Region Information
- 14.1.2. Market Information
- 14.1.3. COVID-19 Impact
- 14.1.4. Background Information
- 14.1.5. Government Initiatives
- 14.1.6. Regulations
- 14.1.7. Regulatory Bodies
- 14.1.8. Major Associations
- 14.1.9. Taxes Levied
- 14.1.10. Corporate Tax Structure
- 14.1.11. Investments
- 14.1.12. Major Companies
- 14.2. Western Europe AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 14.3. Western Europe AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 14.4. Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.5. Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.6. Western Europe AI In Pharma Market: Country Analysis
- 14.7. UK AI In Pharma Market
- 14.8. UK AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 14.9. UK AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 14.10. UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.11. UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.12. Germany AI In Pharma Market
- 14.13. Germany AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 14.14. Germany AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 14.15. Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.16. Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.17. France AI In Pharma Market
- 14.18. France AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 14.19. France AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 14.20. France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 14.21. France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe AI In Pharma Market
- 15.1. Eastern Europe AI In Pharma Market Overview
- 15.1.1. Region Information
- 15.1.2. Market Information
- 15.1.3. COVID-19 Impact
- 15.1.4. Background Information
- 15.1.5. Government Initiatives
- 15.1.6. Regulations
- 15.1.7. Regulatory Bodies
- 15.1.8. Major Associations
- 15.1.9. Taxes Levied
- 15.1.10. Corporate Tax Structure
- 15.1.11. Investments
- 15.1.12. Major Companies
- 15.2. Eastern Europe AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 15.3. Eastern Europe AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 15.4. Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 15.5. Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 15.6. Eastern Europe AI In Pharma Market: Country Analysis
- 15.7. Russia AI In Pharma Market
- 15.8. Russia AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 15.9. Russia AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 15.10. Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 15.11. Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16. North America AI In Pharma Market
- 16.1. North America AI In Pharma Market Overview
- 16.1.1. Region Information
- 16.1.2. Market Information
- 16.1.3. COVID-19 Impact
- 16.1.4. Background Information
- 16.1.5. Government Initiatives
- 16.1.6. Regulations
- 16.1.7. Regulatory Bodies
- 16.1.8. Major Associations
- 16.1.9. Taxes Levied
- 16.1.10. Corporate Tax Structure
- 16.1.11. Investments
- 16.1.12. Major Companies
- 16.2. North America AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 16.3. North America AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 16.4. North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 16.5. North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 16.6. North America AI In Pharma Market: Country Analysis
- 16.7. USA AI In Pharma Market
- 16.8. USA AI In Pharma Market Overview
- 16.8.1. Country Information
- 16.8.2. Market Information
- 16.8.3. COVID-19 Impact
- 16.8.4. Background Information
- 16.8.5. Government Initiatives
- 16.8.6. Regulations
- 16.8.7. Regulatory Bodies
- 16.8.8. Major Associations
- 16.8.9. Taxes Levied
- 16.8.10. Corporate Tax Structure
- 16.8.11. Investments
- 16.8.12. Major Companies
- 16.9. USA AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 16.10. USA AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 16.11. USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 16.12. USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17. South America AI In Pharma Market
- 17.1. South America AI In Pharma Market Overview
- 17.1.1. Region Information
- 17.1.2. Market Information
- 17.1.3. COVID-19 Impact
- 17.1.4. Background Information
- 17.1.5. Government Initiatives
- 17.1.6. Regulations
- 17.1.7. Regulatory Bodies
- 17.1.8. Major Associations
- 17.1.9. Taxes Levied
- 17.1.10. Corporate Tax Structure
- 17.1.11. Investments
- 17.1.12. Major Companies
- 17.2. South America AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 17.3. South America AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 17.4. South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 17.5. South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 17.6. South America AI In Pharma Market: Country Analysis
- 17.7. Brazil AI In Pharma Market
- 17.8. Brazil AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 17.9. Brazil AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 17.10. Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 17.11. Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18. Middle East AI In Pharma Market
- 18.1. Middle East AI In Pharma Market Overview
- 18.1.1. Region Information
- 18.1.2. Market Information
- 18.1.3. COVID-19 Impact
- 18.1.4. Background Information
- 18.1.5. Government Initiatives
- 18.1.6. Regulations
- 18.1.7. Regulatory Bodies
- 18.1.8. Major Associations
- 18.1.9. Taxes Levied
- 18.1.10. Corporate Tax Structure
- 18.1.11. Investments
- 18.1.12. Major Companies
- 18.2. Middle East AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 18.3. Middle East AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 18.4. Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 18.5. Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19. Africa AI In Pharma Market
- 19.1. Africa AI In Pharma Market Overview
- 19.1.1. Region Information
- 19.1.2. Market Information
- 19.1.3. COVID-19 Impact
- 19.1.4. Background Information
- 19.1.5. Government Initiatives
- 19.1.6. Regulations
- 19.1.7. Regulatory Bodies
- 19.1.8. Major Associations
- 19.1.9. Taxes levied
- 19.1.10. Corporate Tax Structure
- 19.1.11. Investments
- 19.1.12. Major Companies
- 19.2. Africa AI In Pharma Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
- 19.3. Africa AI In Pharma Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
- 19.4. Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
- 19.5. Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20. Global AI In Pharma Market Competitive Landscape
- 20.1. Company Profiles
- 20.2. IBM Watson Health
- 20.2.1. Company Overview
- 20.2.2. Products And Services.
- 20.2.3. Business Strategy
- 20.2.4. Financial Overview
- 20.3. Alphabet Inc.
- 20.3.1. Company Overview
- 20.3.2. Products And Services
- 20.3.3. Business Strategy
- 20.3.4. Financial Overview
- 20.4. Concreto HealthAI
- 20.4.1. Company Overview
- 20.4.2. Products And Services
- 20.4.3. Business Strategy
- 20.4.4. Financial Overview
- 20.5. Nvidia Corporation
- 20.5.1. Company Overview
- 20.5.2. Products And Services
- 20.5.3. Business Strategy
- 20.5.4. Financial Overview
- 20.6. PathAI
- 20.6.1. Company Overview
- 20.6.2. Products And Services
- 20.6.3. Business Strategy
- 20.6.4. Financial Overview
21. Key Mergers And Acquisitions In The AI In Pharma Market
- 21.1. Charles River Laboratories Acquired Distributed Bio
- 21.2. Exscientia Acquired Austrian Company Allcyte
- 21.3. Valo Health merged with Khosla Ventures Acquisition
- 21.4. PathAI Merged with Labcorp
22. AI In Pharma Market Future Outlook and Potential Analysis
- 22.1. Global AI In Pharma Market In 2025 - Countries Offering Most New Opportunities
- 22.2. Global AI In Pharma Market In 2025 - Segments Offering Most New Opportunities
- 22.3. Global AI In Pharma Market In 2025 - Growth Strategies
- 22.3.1. Market Trend Based Strategies
- 22.3.2. Competitor Strategies
23. Appendix
- 23.1. Market Data Sources
- 23.2. Research Methodology
- 23.3. Currencies
- 23.4. Research Inquiries
- 23.5. The Business Research Company
- 23.6. Copyright and Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.